A randomized, controlled trial of intravenous clodronate in patients with metastatic bone disease and pain

Journal of Pain and Symptom Management

Volumn 13, Issue 6, 1997, Pages 319-326

  Ernst, D Scott ^a   Brasher, Penny ^a   Hagen, Neil ^a   Paterson, Alexander H G ^a   MacDonald, R Neil ^b   Bruera, Eduardo ^b  

^a TOM BAKER CANCER CENTRE   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

Author keywords

Bone pain; Clodronate; Metastatic bone disease; Osseous metastases

Indexed keywords

CLODRONIC ACID; MORPHINE; PLACEBO; SODIUM CHLORIDE;

ADULT; AGED; ANALGESIC ACTIVITY; ARTICLE; BONE METASTASIS; BONE PAIN; CANCER PAIN; CANCER PALLIATIVE THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, NON-NARCOTIC; ANALYSIS OF VARIANCE; BONE NEOPLASMS; CHI-SQUARE DISTRIBUTION; CLODRONIC ACID; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PAIN, INTRACTABLE; TREATMENT OUTCOME;

EID: 0030955855     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(97)00075-4     Document Type: Article

References (33)

1. Scher HI, Yagoda A. Bone metastases: pathogenesis, treatment and rationale for the use of resorption inhibitors. Am J Med 1987;82:6-28.
2. Tong D, Gillick L, Hendrickson R. The palliation of symptomatic osseous metastases. Cancer 1982;50:893-899.
3. Hanks GW. The pharmacological treatment of bone pain. Cancer Surv 1987;7:87-100.
4. Portenoy RK, Hagen NA. Breakthrough pain: definition, prevalence and characteristics. Pain 1990;41:273-282.
5. Fleisch H. Bisphosphonates. Pharmacology and use in the treatment of tumor-induced hypercalcemia and metastatic bone disease. Drugs 1991;42: 919-944.
6. Flanagan AM, Chambers TJ. Dichloromethylene bisphosphonate (C12MBP) inhibits bone resorption through injury to osteoclasts that resorb C12MBP-coated bone. Bone Miner 1989;6:33-43.
7. Miller SC, Jee WSS. The effect of dichloromethylene diphosphonate on bone and bone cell structure in the growing rat. Anat Rec 1979;193:439-462.
8. O'Rourke NP, McCloskey EV, Vasikaran S, Eyres K, Fern D, Kanis JA. Effective treatment of malignant hypercalcemia with a single intravenous infusion of clodronate. Br J Cancer 1993;67:560-563.
9. Bonjour JP, Rizzoli R. Treatment of hypercalcemia of malignancy with clodronate. Bone 1991;12: S19-S23.
10. Jung A, Chantraine A, Donath A, van Ouwenaller C, Turnill D, Mermillod B, Killer ME. Use of dichloromethylene diphosphonate in metastatic bone disease. New Engl J Med 1983;308:1499-1501.
11. Jung A, van Ouwenaller C, Chantraine A, Courvoisier B. Parenteral diphosphonates for treating malignant hypercalcemia. Cancer 1981;48:1922-1925.
12. Merlini G, Parrinello GA. Long-term effect of parenteral dichloromethylene bisphosphonate on bone disease of myeloma patients treated with chemotherapy. Hematol Oncol 1990;8:23-30.
13. Adami S, Mian M. Clodronate therapy of metastatic bone disease in patients with prostatic carcinoma. Cancer Res 1989;116:67-72.
14. Neri B, Gemelli MT, Sambataro S, et al. Subjective and metabolic effects of clodronate in patients with advanced breast cancer and symptomatic bone metastases. Anticancer Drugs 1992;3:87-90.
15. Luzzani M, Vidili MG, Rissotto R, et al. Disodium clodronate in the treatment of pain due to bone metastases. Int J Clin Pharmacol Res 1990;10: 243-246.
16. Glover D, Lipton A, Keller A, et al. Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. Cancer 1994;74:2949-2955.
17. Thurlimann B, Morani R, Jungi WF, Radziwill A. Pamidronate for pain control in patients with malignant osteolytic bone disease: a prospective dose-effect study. Support Care Cancer 1994;2:61-65.
18. Ernst DS, MacDonald RN, Paterson AHG, Jensen J, Brasher P, Bruera E. A double-blind, cross-over trial of intravenous clodronate in metastatic bone pain. J Pain Symptom Manage 1992;7:4-11.
19. Lahtinen R, Laakso M, Palva I, Virkkunen P, Elomaa I. Randomized, placebo-controlled multicentre trial of clodronate in multiple myeloma. Lancet 1992;340:1049-1052.
20. Elomaa I, Kylmala T, Tammela T, et al. Effect of oral clodronate on bone pain: a controlled study of patients with metastatic prostatic cancer. Int Urol Nephrol 1992;24:159-166.
21. Bruera E, Kuehn N, Miller MJ, et al. The Edmonton symptom assessment system: a simple method for the assessment of palliative care patients. J Palliat Med 1991;7:6-9.
22. Duncan GH, Bushnell MC, Lavigne GJ. Comparison of verbal and visual analogue scales for measuring the intensity and unpleasantness of experimental pain. Pain 1989;37:295-303.
23. Williamson DF, Parker RA, Kendrick JS. The box plot: a simple visual method to interpret data. Ann Intern Med 1989;110:916-921.
24. Bruera E, Schoeller T, Wenk R, et al. A multicentre validation of the Edmonton staging system for cancer pain. J Pain Symptom Manage 1995: 10(5):348-355.
25. Hills M, Armitage P. The two-period cross-over clinical trial. Clin Pharmacol 1979;8:7-20.
26. Bruera E, Miller L, McCallion J, et al. Cognitive failure in patients with terminal cancer: a prospective study. J Pain Symptom Manage 1992;7:192-195.
27. Derogatis L, Morrow G, Fetting J, et al. The prevalence of psychiatric disorders among cancer patients. JAMA 1983;249:751-757.
28. Massie MJ, Holland J. The cancer patients with pain: psychiatric complications and their management. Med Clin North Am 1987;74:243-258.
29. Bruera E, Spachynski K, MacEachern T, Hanson J. Cognitive failure in patients in clinical trials. Lancet 1993;341:247-248.
30. Cleeland C. Assessment of pain in cancer patients: measurement issues. In: Foley KM, Bonica JJ, Ventafridda V, eds. Advances in pain research and therapy, vol 16. Proceedings of the Second International Congress on Cancer Pain 1988. New York: Raven, 1990:47-56.
31. Price DD, McGrath P, Raffi A, et al. The validation of a visual analog scale or ratio scale for pain. Pain 1983;17:45-46.
32. Paterson AHG, Powles TJ, Kanis J, et al. Double blind controlled trial of oral Clodronate in patients with bone metastases from breast cancer. J Clin Oncol 1993;11:59-65.
33. Coleman RE, Vinholes J, Abbey ME, Purhit OP. Double-blind randomized trial of pamidronate for the palliative treatment of metastatic bone disease [Abstract]. ASCO Proceed 1996;15:528.